...
首页> 外文期刊>The journal of immunology >Role of Mitogen-Activated Protein Kinase-Mediated Cytosolic Phospholipase A2 Activation in Arachidonic Acid Metabolism in Human Eosinophils
【24h】

Role of Mitogen-Activated Protein Kinase-Mediated Cytosolic Phospholipase A2 Activation in Arachidonic Acid Metabolism in Human Eosinophils

机译:丝裂原活化的蛋白激酶介导的胞磷脂酶A2激活在人嗜酸性粒细胞花生四烯酸代谢中的作用。

获取原文
           

摘要

The objective of this investigation was to determine the role of secretory and cytosolic isoforms of phospholipase A2 (PLA2) in the induction of arachidonic acid (AA) and leukotriene synthesis in human eosinophils and the mechanism of PLA2 activation by mitogen-activated protein kinase (MAPK) isoforms in this process. Pharmacological activation of eosinophils with fMLP caused increased AA release in a concentration (EC50 = 8.5 nM)- and time-dependent ( t 1/2 = 3.5 min) manner. Both fMLP-induced AA release and leukotriene C4 (LTC4) secretion were inhibited concentration dependently by arachidonic trifluoromethyl ketone, a cytosolic PLA2 (cPLA2) inhibitor; however, inhibition of neither the 14-kDa secretory phospholipase A2 by 3-(3-acetamide-1-benzyl-2-ethylindolyl-5-oxy)propanephosphonic acid nor cytosolic Ca2+-independent phospholipase A2 inhibition by bromoenol lactone blocked hydrolysis of AA or subsequent leukotriene synthesis. Pretreatment of eosinophils with a mitogen-activated protein/extracellular signal-regulated protein kinase (ERK) kinase inhibitor, U0126, or a p38 MAPK inhibitor, SB203580, suppressed both AA production and LTC4 release. fMLP induced phosphorylation of MAPK isoforms, ERK1/2 and p38, which were evident after 30 s, maximal at 1–5 min, and declined thereafter. fMLP stimulation also increased cPLA2 activity in eosinophils, which was inhibited completely by 30 μM arachidonic trifluoromethyl ketone. Preincubation of eosinophils with U0126 or SB203580 blocked fMLP-enhanced cPLA2 activity. Furthermore, inhibition of Ras, an upstream GTP-binding protein of ERK, also suppressed fMLP-stimulated AA release. These findings demonstrate that cPLA2 activation causes AA hydrolysis and LTC4 secretion. We also find that cPLA2 activation caused by fMLP occurs subsequent to and is dependent upon ERK1/2 and p38 MAPK activation. Other PLA2 isoforms native to human eosinophils possess no significant activity in the stimulated production of AA or LTC4.
机译:这项研究的目的是确定磷脂酶A2(PLA2)的分泌和胞浆同工型在人类嗜酸性粒细胞中花生四烯酸(AA)和白三烯合成的诱导中的作用以及丝裂原活化蛋白激酶(MAPK)激活PLA2的机制)在此过程中的同工型。用fMLP进行的嗜酸性粒细胞药理活化导致浓度(EC50 = 8.5 nM)和时间依赖性(t 1/2 = 3.5分钟)的AA释放增加。 fMLP诱导的AA释放和白三烯C4(LTC4)分泌均受胞质PLA2(cPLA2)抑制剂花生四烯酸三氟甲基酮的浓度依赖性抑制。但是,3-(3-乙酰胺-1-苄基-2-苄基吲哚基-5-氧基)丙烷膦酸对14-kDa分泌型磷脂酶A2的抑制作用和溴烯醇内酯对胞内Ca2 +依赖性磷脂酶A2的抑制作用均不能抑制AA或AA的水解。随后的白三烯合成。用促分裂原活化蛋白/细胞外信号调节蛋白激酶(ERK)激酶抑制剂U0126或p38 MAPK抑制剂SB203580预处理嗜酸性粒细胞可抑制AA产生和LTC4释放。 fMLP诱导MAPK亚型ERK1 / 2和p38的磷酸化,在30 s后可见,在1-5分钟时最大,随后下降。 fMLP刺激还增加了嗜酸性粒细胞中cPLA2的活性,这被30μM花生四烯酸三氟甲基酮完全抑制了。用U0126或SB203580对嗜酸性粒细胞进行预温育可阻止fMLP增强的cPLA2活性。此外,抑制ERK的上游GTP结合蛋白Ras也抑制了fMLP刺激的AA释放。这些发现表明,cPLA2激活会导致AA水解和LTC4分泌。我们还发现,由fMLP引起的cPLA2激活发生在ERK1 / 2和p38 MAPK激活之后,并取决于ERK1 / 2和p38 MAPK激活。人类嗜酸性粒细胞天然的其他PLA2同工型在AA或LTC4的刺激产生中没有显着活性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号